Executing M&A in Healthcare

Roy Schoenberg, President & Co-CEO at Amwell - American Well Corporation (NYSE:AMWL) The healthcare industry is a complex and rigid space where change is often rejected. Any evolution in this sector not only signifies business decisions but also influences the overall quality and accessibility of patient care.  In this episode of the M&A Science Podcast, Roy Schoenberg, President & Co-CEO at Amwell, delves into the intricacies of navigating M&A in the healthcare industry. ____________________________________________________________________________ This episode is sponsored by the M&A Science Academy, DealRoom, and FirmRoom.  To join our growing online community of M&A practitioners, visit www.mascience.com/academy.  Ready to take your M&A to the next level with software made to manage each stage of the deal process? See how DealRoom can facilitate your next deal at www.dealroom.net. FirmRoom provides 80% cost savings over VDRs that bill by page and delivers a far better user experience to boot. Sign up in under 2 minutes by going to www.firmroom.com. Episode Timestamps 00:00 Intro 04:26 Evolving from a medical background to M&A 07:27 What makes the healthcare space distinct 09:36 What drove Amwell to do acquisitions 13:03 Shaping the acquisition strategy 16:59 Amwell’s first acquisition 22:29 Integrating the new company 24:50 Retaining key people 28:33 First acquisition lessons learned 31:03 Dealing with transaction surprises 34:03 Approaching deals as one of the main principal 38:01 Deal sourcing 39:49 Managing relationships with the counterparty 41:30 Communication during diligence 43:14 Craziest thing in M&A